News · Yahoo Finance

Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?

Ark Investment Management, led by Cathie Wood, holds $220.4 million in Beam Therapeutics (BEAM) shares through its Ark ETFs, and recently bought another $2.8 million worth on Oct. 12 and 13 for the Ark Genomic Revolution (ARKG) fund. Beam develops gene-editing therapies using base editing, which changes single nucleotides without cutting both DNA strands, and its lead candidate, risto-cel, is in early trials for severe sickle cell disease. The company is far from profitable: first-half revenue was $32.2 million, up 50.5%, and loss per share was $2.09 versus $2.12 a year earlier, while $1.15 billion in cash is expected to fund operations through mid-2029. The stock is down more than 14% this year, and the article notes that the next 12 to 18 months will bring dense data readouts that could significantly lift the shares if positive.

Summary written by Upside AI from the original article. Read the source for full details.

Read the original on Yahoo Finance ↗

Keywords

Cathie WoodBeam TherapeuticsETFbiotechnology

Open a keyword to see other news on the same topic.

Related news

  • Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.

    Ark Invest founder Cathie Wood holds $379.1 million of CRISPR Therapeutics shares and bought $1.1 million on Oct. 9 and $2.3 million on Oct. 12 through the ARK Genomic Revolution ETF, even though the stock is down more than 25% over the past year. CRISPR's only approved therapy, Casgevy, posted $76 million in Q2 revenue, up 151% year over year, but its $2.2 million list price and the 60% revenue share going to Vertex limit its economics. The company's net loss narrowed to $91.2 million from $208.5 million, and it holds $2.36 billion in cash. The article also points to CTX-310, which cut LDL cholesterol by 53% and triglycerides by 48% after 12 months in a phase 1a trial, and to a phase 2 readout for blood thinner CTX611 expected later this year.

    Yahoo Finance·Cathie WoodCRISPR TherapeuticsETF
  • Cathie Wood Is Buying Shares of This Bargain “Magnificent Seven” Stock Before Oct. 21. Should You?

    Ark Invest's Cathie Wood bought 20,125 Meta Platforms shares on October 13 and 9,577 more the next day for her Ark Next Generation Technology ETF, where Meta is the second-largest holding at a 5.7% weight. The article links the move to Meta's AI push: its personal AI agent Muse launched last month and its downloads reached 5 million, ahead of ChatGPT and Claude after their launches, while Meta released Muse Wonder and Muse Wonder Full models this week. Meta reports third-quarter earnings on October 21, when investors will watch its capital spending and AI monetization, and the stock trades at 24x forward earnings, higher than in recent months but still inexpensive given its business. The author argues long-term investors do not need to rush ahead of the report, since gains or losses over days or weeks have little impact over five or 10 years.

    Yahoo Finance·
  • Cathie Wood Keeps Buying Rocket Lab Stock as It Trades at Less Than Half Its Record

    ARK Invest has bought nearly 1.3 million Rocket Lab (RKLB) shares in three waves from late August to Oct. 1, worth over $85 million, as the stock trades at under half its late-May record close of about $150. ARK argues that if SpaceX scales Starship toward 10,000 launches a year by 2030 and retires Falcon 9 by the end of the decade, the U.S. could face a launch shortage that Rocket Lab's Neutron rocket could help fill, though Neutron has not flown yet. Backlog hit a record $2.36 billion as of June 30, up 137% year over year, but Neutron's launch timing is uncertain and second-quarter free cash flow was negative $110 million. Rocket Lab raised about $1.94 billion by selling roughly 29.3 million shares, which dilutes current shareholders. At about $68 a share, the company is valued near $46 billion, or about 44 times sales, and the author would want to see Neutron fly before buying.

    Yahoo Finance·
  • Cathie Wood’s ARK Buys CoreWeave. The Case for Buying Now.Yahoo Finance·
  • Billionaires Are Selling These 6 Artificial Intelligence (AI) Stocks. Should You Follow?

    In Q2, billionaires or their funds sold six Magnificent Seven stocks: Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), Alphabet (GOOG/GOOGL), Meta Platforms (META) and Tesla (TSLA). The author advises retail investors not to simply copy billionaires, since hedge funds trade on shorter horizons and their trades are often disclosed only months later. Investors are wary of AI spending, as hyperscalers commit hundreds of billions of dollars to infrastructure and some companies are generating negative free cash flow. He suggests evaluating each company individually, favouring Amazon, whose planned $220 billion of capital expenditure is offset by 37% AWS revenue growth, and Apple, which has not invested heavily in data centers. He would avoid Tesla, whose valuation of nearly 215 times forward earnings already assumes major success in its robotaxi and humanoid robot businesses.

    Yahoo Finance·▼ NVDA
  • Should You Invest in This Dividend King on the Dip?

    Johnson & Johnson (JNJ) shares fell significantly after its third-quarter results, even though the company beat expectations and slightly raised its full-year guidance. Revenue reached $25.4 billion, up 5.9%, while adjusted EPS of $2.59 fell 7.5%, a decline the company attributed mostly to acquisitions. Innovative medicine sales rose 7.7% to $16.8 billion, led by Darzalex and Tremfya, but medtech revenue of $8.6 billion, up 2.5%, fell short of expectations and drove the post-earnings dip, with the cardiovascular unit hurt by safety and efficacy concerns about the Impella heart pumps. The article points to new drugs such as ICOTYDE and Imaavy as medium-term growth drivers and says the Ottava robotic surgery device could help medtech recover. The author argues investors should hold the stock for the long term, citing JNJ's 64 consecutive years of dividend increases.

    Yahoo Finance·

Related markets

US stocks →

Latest news

  • TRX Gold to Present at Red Cloud's Fall Mining Showcase 2026

    TRX Gold will present at Red Cloud's Fall Mining Showcase 2026, an in-person conference at the Omni King Edward Hotel in Toronto on October 28 and 29, 2026. Stephen Mullowney is scheduled to present on Thursday, October 29, 2026 at 12:00 PM Eastern. The release describes the company as a gold producer advancing the Buckreef Gold Project in Tanzania, which includes an established open pit and a 2,000 tonnes per day plant. The May 2025 PEA outlines average annual gold production of 62,000 oz over 17.6 years.

    Yahoo Finance·goldminingTRX Gold
  • Tesla Stock vs. the S&P 500: Which Investment Wins Through 2030?

    The article argues Tesla trades at roughly 203 times this year's expected earnings and 13 times expected sales, a valuation that looks very expensive given gross margin pressure and a slower-than-expected robotaxi rollout. The flying Roadster, slated for production in 2028, is unlikely to make a meaningful sales or earnings contribution before 2030. The author thinks a Tesla-SpaceX merger by the end of the decade, likely an all-stock deal, is more likely than not and would be a key factor in how Tesla stock performs against the S&P 500 through 2030.

    Yahoo Finance·TeslaS&P 500valuation
  • SpaceX surprises Wall Street with Oct. 20 earnings date — here's why

    SpaceX (SPCX) will release earnings on Oct. 20 after the market close, a surprise since earnings dates are usually shared weeks in advance. Evercore ISI analyst Kutgun Maral says possible reasons include putting updated financials on record before new financing or getting ahead of major lock-up releases, though scheduling is also possible. Reuters reported SpaceX is seeking $40 billion in financing to buy advanced Nvidia AI chips, including about $10 billion in bank loans and $30 billion in investment-grade debt, with Apollo expected to lead. The lock-up schedule includes 1.30 billion shares two days after earnings, 329 million on 10/24, and a remaining 857 million tranche of the 180-day group.

    Yahoo Finance·SpaceXearningsIPO
  • AEP Partners with Amazon and X-energy to Explore Advanced Nuclear Energy in Indiana

    American Electric Power (AEP) has announced a joint development agreement with X-energy to evaluate the feasibility of a 960-megawatt advanced nuclear project at a former coal plant site in Sullivan County, Indiana. Amazon is supporting development through a funding agreement. If the project reaches a final investment decision and is built, Amazon intends to buy the power under a long-term contract covering the facility's costs and operations. The initial project would include 12 Xe-100 units of 80 MW each, and the companies say it could create jobs, expand the local tax base and strengthen the grid for more than 60 years. AEP says the agreements include the financial safeguards it considers essential for any nuclear project to move forward.

    Yahoo Finance·• AMZNAmerican Electric PowerAmazonnuclear energy
  • Talamore Marks One Year at Coffee with Major Advances Toward a 2027 Construction Decision

    Talamore Mining marks one year since closing its acquisition of the Coffee Gold Project in Yukon, Canada, from Newmont Corporation on October 17, 2025. The company has assembled a financing package of up to C$688 million, including a C$149.5 million equity offering, a C$450 million secured project debt facility and up to C$88 million from a warrant early-exercise program. A primary road permit received in August 2026 allows completion of the 214-kilometre Northern Access Route from Dawson City. The February 2026 Preliminary Economic Assessment outlined a 13-year open-pit heap leach mine with an after-tax NPV (5%) of US$2.3 billion and an after-tax IRR of 47.8%. G Mining Services is completing the Feasibility Study, expected in Q1 2027, ahead of a construction decision targeted for the first half of 2027.

    Yahoo Finance·goldminingTalamore Mining
  • Tiger Gold Extends Mineralization to the South at Ceibal, Drilling 268 m @ 0.5 g/t Au from Surface

    Tiger Gold reported assay results from hole CEDDH-023 at its Ceibal target within the Quinchía Gold Project in Colombia. The hole intersected 268 metres grading 0.5 g/t Au from surface, extending mineralization south into a previously untested part of the corridor. Mineralization remains open to the west and southwest, where additional holes are testing for extension, and assays from Ceibal and Tesorito are pending. The drilling is intended to support a maiden Mineral Resource estimate, targeted for near the end of Q1 2027.

    Yahoo Finance·goldminingTiger Gold

All news →

Get the briefing on Telegram or Zalo

Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.